Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2017
  • Online publication date: August 2017

Chapter 12 - Biopsychosocial Factors in Premenstrual Syndrome

from Section 2 - Gynaecology
1.Halbreich, U, Borenstein, J, Pearlstein, T, Kahn, LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003; 28: 123.
2.Pearlstein, T. Prevalence, impact, on morbidity and burden of disease. In: O’Brien, PMS, Rapkin, A, Schmidt, P (eds.) The Premenstrual Syndromes: PMS and PMDD. London: Informa Healthcare. 2007; 3747.
3.Magos, AL, Studd, JWW. The premenstrual syndrome. In: Studd, J (ed.) Progress in Obstetrics and Gynaecology, Volume 4. London: Churchill Livingstone. 1984; 334–50.
4.O’Brien, PM, Bäckström, T, Brown, C, Dennerstein, L, Endicott, J, Epperson, CN, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: The ISPMD Montreal consensus. Archives of Women’s Mental Health 2011; 14(1): 1321.
5.Royal College of Obstetricians and Gynaecologists. Premenstrual Syndrome. Management. Green-top guideline 48. 2nd ed. RCOG Press, 2016. www.rcog.org.uk/globalassets/documents/guidelines/gt48managementpremensturalsyndrome.pdf. (Accessed 23 March 2017).
6.Gianetto-Berruti, A, Feyles, V. Premenstrual syndrome. Minerva Ginecologica 2002; 54(2): 8595.
7.O’Brien, S, Ismail, K. History of the premenstrual disorders. In: O’Brien, PM, Rapkin, AJ, Schmidt, PJ (eds.). The Premenstrual Syndromes: PMS and PMDD. London: Informa Healthcare. 2007.
8.Wyatt, K, Dimmock, P, Jones, P, Obhrai, M, O’Brien, S. Efficacy of progesterone and progestogens in management of premenstrual syndrome: Systematic review. BMJ 2001; 323: 776.
9.Ford, O, Lethaby, A, Roberts, H, Mol, BW. Progesterone for premenstrual syndrome. Cochrane Database Syst Rev 2009; 2: CD003415.
10.Premenstrual dysphoric disorder. In: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press, 2000: 771–74.
11.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: 1987.
12.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-5. 5th ed. Arlington, VA: American Psychiatric Association Publishing: 2013.
13.O’Brien, S, Rapkin, A, Dennerstein, L, Nevatte, T. Diagnosis and management of premenstrual syndrome. BMJ 2011; 342: d2994.
14.ACOG practice bulletin: Premenstrual syndrome. Int J Gynecol Obstet 2001; 73: 183–91.
15.Kessler, R. Epidemiology of women and depression. J Affect Disord 2003; 74(1): 513.
16.Yonkers, KA, McCunn, KL. Comorbidity of premenstrual syndrome and premenstrual dysphoric disorder with other psychiatric conditions. In: O’Brien, PM, Rapkin, AJ, Schmidt, PJ (eds.) The Premenstrual Syndromes: PMS and PMDD. London: Informa Healthcare. 2007.
17.Rapkin, AJ, Chang, LC, Reading, AE. Comparison of retrospective and prospective assessment of premenstrual symptoms. Psychol Rep 1988; 62: 5560.
18.Endicott, J, Nee, J, Harrison, W. Daily record of severity of problems (DRSP): Reliability and validity. Archives of women’s mental health 2006; 9: 4149.
19.Steiner, M, Macdougall, M, Brown, E. The premenstrual symptoms screening tool (PSST) for clinicians. Archives of women’s mental health 2003; 6: 203–9.
20.Nevatte, T, O’Brien, PMS, Bäckström, T, et al. ISPMD consensus on the management of premenstrual disorders. Archives of women’s mental health 2013; 16(4): 279–91.
21.Case, AM, Reid, RL. Effects of the menstrual cycle on medical disorders. Arch Intern Med 1998; 158: 1405–12.
22.Girman, A, Lee, R, Kligler, B. An integrative medicine approach to premenstrual syndrome. Am J Obstet Gynecol 2003; 188(5 suppl): S5665.
23.Thys-Jacobs, S, Starkey, P, Bernstein, D, Tian, J. Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol 1998; 179(2): 444–52.
24.Oleson, T, Flocco, W. Randomised controlled study of premenstrual symptoms treated with ear; hand and foot reflexology. Obstet Gynecol 1993; 82: 906–11.
25.Sun, Y, Guo, S. Comparison of therapeutic effects of acupuncture and medicine on premenstrual syndrome. Chinese Acupunct Moxib 2004; 24(1): 2930.
26.Hunter, MS, Ussher, JM, Browne, SJ, Cariss, M, Jelley, R, Katz, M. A randomized comparison of psychological (cognitive behaviour therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder. J Psychosom Obstet Gynecol 2002; 23: 193–99.
27.Eriksson, E, Ekman, A, Sinclair, S, Sörvik, K, Ysander, C, Mattson, UB, Nissbrandt, H. Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder. J Clin Psychopharmacol 2008 April; 28(2): 195202.
28.Pedersen, LH, Henriksen, TB, Vestergaard, M, Olsen, J, Bech, BH. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: Population based cohort study. BMJ 2009; 339: b3569.
29.Lopez, LM, Kaptein, AA, Helmerhorst, FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database of Systematic Reviews 2012; 2: CD006586.
30.Pearlstein, TB, Bachmann, GA, Zacur, HA, Yonkers, KA. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 2005; 72: 414–21.
31.Coffee, AL, Kuehl, TJ, Willis, S, Sulak, PJ. Oral contraceptives and premenstrual symptoms: Comparison of a 21/7 and extended regimen. Am J Obstet Gynecol 2006; 195: 1311–19.
32.Panay, N, Studd, JWW. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997; 3: 159–71.
33.Wyatt, KM, Dimmock, PW, Ismail, KM, O’Brien, PMS. The effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: A meta-analysis. Br J Obstet Gynaecol 2004; 111: 585–93.
34.O’Brien, PM, Abukhalil, IE. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. Am J Obstet Gynecol 1999 January; 180: 1823.
35.Cronje, WH, Vashisht, A, Studd, JW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod 2005; 19: 2125–5.
36.Nappi, RE, Wawra, K, Schmitt, S. Hypoactive sexual desire disorder in postmenopausal women. Gynecol Endocrinol 2006; 22: 318–23.